AtriCure
ATRC
ATRC
212 hedge funds and large institutions have $1.42B invested in AtriCure in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 70 increasing their positions, 71 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
1% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 71
5.66% less ownership
Funds ownership: 101.02% → 95.35% (-5.7%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
212
Holding in Top 10
2
Calls
$1.25M
Puts
$138K
Top Buyers
| 1 | +$13.2M | |
| 2 | +$9.17M | |
| 3 | +$5.28M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$5.12M |
| 5 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$4.63M |
Top Sellers
| 1 | -$33.1M | |
| 2 | -$27.2M | |
| 3 | -$9.19M | |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$8.01M |
| 5 |
SAM
Silvercrest Asset Management
New York
|
-$7.5M |